Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met

Clinical and Experimental Metastasis

Volumn 31, Issue 1, 2014, Pages 1-14

  Harun, Nadia ^a   Costa, Patricia ^a   Christophi, C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

c Met; Growth factors; Hepatectomy; Liver metastases; Liver regeneration

Indexed keywords

EID: 84894951202     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9604-7     Document Type: Article

References (61)

1. Saenz NC, Cady B, McDermott WV Jr, Steele GD Jr (1989) Experience with colorectal carcinoma metastatic to the liver. Surg Clin North Am 69(2):361-370
2. Pestana C, Reitemeier RJ, Moertel CG, Judd ES, Dockerty MB (1964) The natural history of carcinoma of the colon and rectum. Am J Surg 108:826-829
3. Koh SL, Ager EI, Christophi C (2010) Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int 30(10):1414-1426. doi: 10.1111/j.1478-3231.2010.02306.x
4. Christophi C, Harun N, Fifis T (2008) Liver regeneration and tumor stimulation-a review of cytokine and angiogenic factors. J Gastrointest Surg 12(5):966-980. doi: 10.1007/s11605-007-0459-6
5. de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L, Pawlik TM (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250(3):440-448. doi: 10.1097/SLA.0b013e3181b4539b
6. Lukomska B, Dluzniewska J, Polanski J, Zajac L (2004) Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 3(1):S52. doi: 10.1186/1476-5926-2-S1-S521476- 5926-2-S1-S52
7. Dluzniewska J, Zolich D, Polanski J, Zajac L, Sitkiewicz D, Lukomska B (2002) Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy. Med Sci Monit 8(10):690-696
8. Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13(3):353-362. doi: 10.1245/ASO.2006.03.060
9. Rupertus K, Kollmar O, Scheuer C, Junker B, Menger MD, Schilling MK (2007) Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis 24(1):39-48. doi: 10.1007/s10585-006-9054-6
10. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS (2004) Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101(13):4477-4482. doi: 10.1073/pnas.0306068101
11. Michalopoulos GK, Khan Z (2005) Liver regeneration, growth factors, and amphiregulin. Gastroenterology 128(2):503-506
12. Natarajan A, Wagner B, Sibilia M (2007) The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA 104(43):17081-17086. doi: 10.1073/pnas.0704126104
13. Bohm F, Kohler UA, Speicher T, Werner S (2010) Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2(8):294-305. doi: 10.1002/emmm.201000085
14. Factor VM, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen JB, Conner EA, Thorgeirsson SS (2010) Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One 5(9):e12739. doi: 10.1371/journal.pone.0012739
15. Desbois-Mouthon C, Wendum D, Cadoret A, Rey C, Leneuve P, Blaise A, Housset C, Tronche F, Le Bouc Y, Holzenberger M (2006) Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J 20(6):773-775. doi: 10.1096/fj.05-4704fje
16. Peruzzi B, Bottaro DP (2006) Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12(12):3657-3660. doi: 10.1158/1078-0432.CCR-06-0818
17. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R (2002) Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 13(1):41-59
18. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366(1):2-16. doi: 10.1016/j.gene.2005. 10.018
19. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107(1-3):233-235
20. Hellstrom I, Hellstrom KE, Nishioka M (1975) Reactivity to tumour-associated antigens detected in mice undergoing liver regeneration. Nat 253(5494):744-746
21. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surg 124(1):57-64. doi: S0039606098002025
22. Asaga T, Suzuki K, Umeda M, Sugimasa Y, Takemiya S, Okamoto T (1991) The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn J Surg 21(6):669-675
23. Krause P, Flikweert H, Monin M, Seif Amir Hosseini A, Helms G, Cantanhede G, Ghadimi BM, Koenig S (2013) Increased growth of colorectal liver metastasis following partial hepatectomy. Clin Exp Metastasis 30(5):681-693. doi: 10.1007/s10585-013-9572-y
24. Harun N, Nikfarjam M, Muralidharan V, Christophi C (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138(2):284-290. doi: 10.1016/j.jss.2006.06.024
25. Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C (2007) Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 22(4):577-584. doi: 10.1111/j.1440-1746.2006.04797.x
26. Kuruppu D, Christophi C, Bertram JF, O'Brien PE (1996) Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol 11(1):26-32
27. Nagel JD, Kort WJ (1992) A new liver-tumor model in the rat. Cancer Chemother Pharmacol 30(1):70-72
28. Nikfarjam M, Malcontenti-Wilson C, Fanartzis M, Daruwalla J, Christophi C (2004) A model of partial hepatectomy in mice. J Invest Surg 17(5):291-294. doi: 10.1080/0894193049050287158K3BR487URA1N6N
29. Ager EI, Chong WW, Wen SW, Christophi C (2010) Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases. Cancer Cell Int 10:19. doi: 10.1186/1475-2867-10-19
30. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK (1999) Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 59(16):3954-3960
31. Meredith K, Haemmerich D, Qi C, Mahvi D (2007) Hepatic resection but not radiofrequency ablation results in tumor growth and increased growth factor expression. Ann Surg 245(5):771-776. doi: 10.1097/01.sla.0000261319.51744.59
32. Lim C, Cauchy F, Azoulay D, Farges O, Ronot M, Pocard M (2013) Tumour progression and liver regeneration-insights from animal models. Nat Rev Gastroenterol Hepatol. doi: 10.1038/nrgastro.2013.55
33. Tanaka K, Hiroshima Y, Nakagawa K, Kumamoto T, Nojiri K, Takeda K, Ota M, Ichikawa Y, Endo I (2013) Two-stage hepatectomy with effective perioperative chemotherapy does not induce tumor growth or growth factor expression in liver metastases from colorectal cancer. Surg 153(2):179-188. doi: 10.1016/j.surg.2012.06.026
34. Stolz DB, Ross MA, Salem HM, Mars WM, Michalopoulos GK, Enomoto K (1999) Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. Am J Pathol 155(5):1487-1498. doi: 10.1016/S0002-9440(10)65464-8
35. Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Sci 276(5309):60-66
36. Ross MA, Sander CM, Kleeb TB, Watkins SC, Stolz DB (2001) Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatol 34(6):1135-1148. doi: 10.1053/jhep.2001.29624
37. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C (2004) Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 101(29):10608-10613. doi: 10.1073/pnas.0403412101
38. Santos A, Yusta B, Fernandez-Moreno MD, Blazquez E (1994) Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver. Mol Cell Endocrinol 101(1-2):85-93
39. Michalopoulos GK (2010) Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 176(1):2-13. doi: 10.2353/ajpath.2010.090675
40. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95(4):1789-1797. doi: 10.1172/JCI117857
41. Baker CH, Kedar D, McCarty MF, Tsan R, Weber KL, Bucana CD, Fidler IJ (2002) Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161(3):929-938. doi: 10.1016/S0002-9440(10)64253-8
42. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D (2002) Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62(4):1030-1035
43. Winder T, Lenz HJ (2010) Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterol 138(6):2163-2176. doi: 10.1053/j.gastro.2010.02.005
44. Bid HK, Zhan J, Phelps DA, Kurmasheva RT, Houghton PJ (2012) Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2. Mol Cancer Ther 11(3):649-659. doi: 10.1158/1535-7163.MCT- 11-0575
45. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S et al (1995) Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1(2):147-154
46. De Oliveira AT, Matos D, Logullo AF, DAS SR, Neto RA, Filho AL, Saad SS (2009) MET Is highly expressed in advanced stages of colorectal cancer and indicates worse prognosis and mortality. Anticancer Res 29(11):4807-4811
47. Sierra JR, Tsao MS (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3(1):S21-S35. doi: 10.1177/ 1758834011422557
48. Efferth T (2012) Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr Med Chem 19(33):5735-5744
49. Ewing GP, Goff LW (2010) The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma. Clin Colorectal Cancer 9(4):219-223. doi: 10.3816/CCC.2010.n.032
50. Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takagi H, Mori M (2002) Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncog 21(12):1791-1799. doi: 10.1038/sj.onc.1205248
51. Casanova ML, Larcher F, Casanova B, Murillas R, Fernandez-Acenero MJ, Villanueva C, Martinez-Palacio J, Ullrich A, Conti CJ, Jorcano JL (2002) A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 62(12):3402-3407
52. Xue M, Cao X, Zhong Y, Kuang D, Liu X, Zhao Z, Li H (2012) Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives. Curr Pharm Des 18(20):2901-2913
53. Pietras K, Pahler J, Bergers G, Hanahan D (2008) Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5(1):e19. doi: 10.1371/journal.pmed.0050019
54. Fifis T, Malcontenti-Wilson C, Amijoyo J, Anggono B, Muralidharan V, Nikfarjam M, Christophi C (2011) Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases. HPB 13(4):246-255. doi: 10.1111/j.1477-2574.2010.00278.x
55. Wu F, Wu L, Zheng S, Ding W, Teng L, Wang Z, Ma Z, Zhao W (2006) The clinical value of hepatocyte growth factor and its receptor-c-met for liver cancer patients with hepatectomy. Dig Liver Dis 38(7):490-497. doi: 10.1016/j.dld.2006.03.007
56. Osada S, Matsui S, Komori S, Yamada J, Sanada Y, Ihawa A, Tanaka Y, Tokuyama Y, Okumura N, Nonaka K, Hosono Y, Takahashi T, Yamaguchi K, Yoshida K (2010) Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer. Hepatogastroenterol 57(97):76-80
57. Greenall SA, Gherardi E, Liu Z, Donoghue JF, Vitali AA, Li Q, Murphy R, Iamele L, Scott AM, Johns TG (2012) Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET. PLoS ONE 7(4):e34658. doi: 10.1371/journal.pone.0034658
58. de Jong GM, Hendriks T, Eek A, Oyen WJ, Nagtegaal ID, Bleichrodt RP, Boerman OC (2011) Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases. Ann Surg 253(2):336-341. doi: 10.1097/SLA.0b013e3181ff313a
59. Wu Y, Brodt P, Sun H, Mejia W, Novosyadlyy R, Nunez N, Chen X, Mendoza A, Hong SH, Khanna C, Yakar S (2010) Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis. Cancer Res 70(1):57-67. doi: 10.1158/0008-5472.CAN-09-2472
60. Karpoff HM, Tung C, Ng B, Fong Y (1996) Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity. Hepatol 24(2):374-379. doi: S027091399600333310.1002/hep.510240214
61. Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46(10):5049-5053